Engineering perfused microvascular networks into microphysiological systems platforms. (March 2018)

• Record Type: Journal Article
• Authors: Andrejecsk, Jillian W.; Hughes, Christopher C.W.
• Is Part Of: Current opinion in biomedical engineering. Volume 5(2018)
• Page Start: 74
• Page End: 81
• Publication Date: 2018-03
• Subjects: Perfused vessels -- Microvascular networks -- Microphysiological systems -- Organ-on-a-chip -- Tumor models -- Drug screening; Biomedical engineering -- Periodicals; 610.28
• DOI: 10.1016/j.cobme.2018.02.002
• Languages: English
• ISSNs: 2468-4511

Abstract

Abstract: The microvasculature is an essential component of nearly all tissues, with most cells residing within 200 μm of a vessel. Endothelial cells form the inner wall of microvessels and control which nutrients, cells and drugs cross into the underlying tissue. Given these critical roles, it makes sense to include functioning microvessels when creating tissue models, and these can be generated by pre-patterning of channels, 3D printing, or by "biology-directed" vasculogenesis and angiogenesis. These methods have been used to create tissue-specific vascularized micro-organs, vascularized microtumors, and vascular beds for studying tumor cell and immune cell extravasation. Recent innovations in 3D printing and high-throughput technologies have enabled more complex geometries and facilitated more comprehensive studies. Future developments hold promise for increasingly relevant models of healthy and diseased tissues, with implications for studying biological mechanisms and screening for new drugs. Highlights: Inclusion of perfused microvasculature in microphysiological systems increases their relevance as in vivo models. Networks can be formed by channel patterning, 3D-printing or biology-directed vasculogenesis. Organ-specific vasculature can be generated, and both healthy and diseased vascularized tissues can be studied. Perfused microvessels allow for drug distribution (PK/PD) studies in vitro . Recent innovations include tumor models, cancer cell extravasation, 3D printing advances, and HTP technologies.